Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Postdoctoral Fellowships

Institut national de la recherche scientifique

$45,000.00

More convenient and less expensive monoclonal antibody therapies achieved by reducing viscosity.

EF 2019-20

Résumé
Monoclonal antibody (mAb), Viscosity, Clusters, PEGylation, Protein therapeutics, Protein - protein interaction, Scale-up manufacturing of mAb, Target-binding regions of mAb, Rheological properties
Programme
Postdoctoral Fellowships
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
516738-2018
Name nom
SoleymaniAbyaneh, Hoda
Department département
Énergie Matériaux Télécommunications, Centre - Montréal
Organization id
56
Institution établissement
Institut national de la recherche scientifique
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
45000
Program id
PDF
Program name en
Postdoctoral Fellowships
Program name fr
Bourses postdoctorales
Group en
RESEARCH TRAINING AND TALENT DEVELOPMENT
Group fr
FORMATION EN RECHERCHE ET PERFECTIONNEMENT DES COM
Committee code
194
Committee name en
S&F Selection Committee for Engineering B
Committee name fr
Comité de sélection des bourses en génie B
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Installment
inst:4 - 5
Partie
4
Nb partie
5
Application title
More convenient and less expensive monoclonal antibody therapies achieved by reducing viscosity.
Keyword
NSERC
Application summary
Monoclonal antibody (mAb), Viscosity, Clusters, PEGylation, Protein therapeutics, Protein - protein interaction, Scale-up manufacturing of mAb, Target-binding regions of mAb, Rheological properties